Literature DB >> 17095878

Application of the standard photodynamic treatment protocol for symptomatic circumscribed choroidal hemangioma.

Joaquin Vicuna-Kojchen1, Eyal Banin, Edward Averbukh, Israel Barzel, Marina Shulman, Itzhak Hemo, Jacob Pe'er, Itay Chowers.   

Abstract

PURPOSE: To describe the results of photodynamic therapy (PDT) using a standard protocol, developed for treating choroidal neovascularization (CNV), for the treatment of circumscribed choroidal hemangioma (CCH).
METHODS: A prospective, uncontrolled, consecutive case series of patients with symptomatic CCH that were treated using the standard PDT protocol was evaluated periodically with ophthalmic exams and echography.
RESULTS: Nine CCH patients were included in the study. Mean tumor height decreased from 2.7 mm before treatment to 0.8 mm at the end of the follow-up period. Mean visual acuity improved from 6/15 to 6/12. Six patients required one PDT session, two patients two sessions, and one patient three sessions. Side effects included transient visual disturbances in two patients. One patient, who concomitantly presented with age-related macular degeneration, developed CNV.
CONCLUSIONS: The standard PDT protocol is effective for the treatment of CCH. Complications are uncommon. Further studies should assess the optimal PDT protocol for the treatment of CCH. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17095878     DOI: 10.1159/000095859

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  5 in total

1.  Comparison of outcomes between overlapping-spot and single-spot photodynamic therapy for circumscribed choroidal hemangioma.

Authors:  Zhao-An Su; Xia-Jing Tang; Li-Xia Zhang; Xiao-Hong Su
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

2.  A case of circumscribed choroidal hemangioma in Sturge-Weber syndrome in China.

Authors:  Xiao-Lei Yin; Jian Ye; Rong-Di Yuan; Shu-Xing Ji
Journal:  Int J Ophthalmol       Date:  2011-04-18       Impact factor: 1.779

3.  Clinical outcomes and predictors of response to photodynamic therapy in symptomatic circumscribed choroidal hemangioma: A retrospective case series.

Authors:  Yeen-Fey Ho; Anne Chao; Kuan-Jen Chen; An-Ning Chao; Nan-Kai Wang; Laura Liu; Yen-Po Chen; Yih-Shiou Hwang; Wei-Chi Wu; Chi-Chun Lai; Tun-Lu Chen
Journal:  PLoS One       Date:  2018-05-31       Impact factor: 3.240

4.  Application of ICG-enhanced thermocoagulation method and photodynamic therapy in circumscribed choroidal hemangioma.

Authors:  Chuan Tian; Xi Chen; Jin Cao; Lu Yang
Journal:  Oncol Lett       Date:  2018-02-15       Impact factor: 2.967

5.  High recurrence rate in patients with choroidal hemangioma treated with limited single spot photodynamic therapy during long-term follow-up.

Authors:  Marilette Stehouwer; Reinier O Schlingemann; Frank D Verbraak
Journal:  Acta Ophthalmol       Date:  2020-04-14       Impact factor: 3.761

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.